Renalytix plc·4

Nov 22, 4:27 PM ET

Doran Howard JR 4

4 · Renalytix plc · Filed Nov 22, 2023

Insider Transaction Report

Form 4
Period: 2023-11-20
Doran Howard JR
Chief Business Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2023-11-20+300,000300,000 total
    Exercise: $0.30Exp: 2033-11-19Ordinary Shares (300,000 underlying)
Footnotes (2)
  • [F1]The exercise price is 0.245 pounds sterling. The U.S. dollar equivalent of the exercise price is $0.304 using the Bank of England rate as of November 17, 2023 (1.00 pound sterling = $1.243).
  • [F2]One third (1/3rd) of the shares subject to the option award shall vest on September 1, 2024, and one eighth (1/8th) of the remaining shares subject to the option award shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION